A dual‐tracer study of extrastriatal 6‐[18F]fluoro‐m‐tyrosine and 6‐[18F]‐fluoro‐l‐dopa Uptake in Parkinson's disease. Issue 8 (22nd April 2014)
- Record Type:
- Journal Article
- Title:
- A dual‐tracer study of extrastriatal 6‐[18F]fluoro‐m‐tyrosine and 6‐[18F]‐fluoro‐l‐dopa Uptake in Parkinson's disease. Issue 8 (22nd April 2014)
- Main Title:
- A dual‐tracer study of extrastriatal 6‐[18F]fluoro‐m‐tyrosine and 6‐[18F]‐fluoro‐l‐dopa Uptake in Parkinson's disease
- Authors:
- Li, Clarence T.
Palotti, Matthew
Holden, James E.
Oh, Jen
Okonkwo, Ozioma
Christian, Bradley T.
Bendlin, Barbara B.
Buyan‐Dent, Laura
Harding, Sandra J.
Stone, Charles K.
DeJesus, Onofre T.
Nickles, Robert J.
Gallagher, Catherine L. - Abstract:
- <abstract abstract-type="main"> <title>ABSTRACT</title> <p>6‐[<sup>18</sup>F]‐Fluoro‐<sc>l</sc>‐dopa (FDOPA) has been widely used as a biomarker for catecholamine synthesis, storage, and metabolism—its intense uptake in the striatum, and fainter uptake in other brain regions, is correlated with the symptoms and pathophysiology of Parkinson's disease (PD). 6‐[<sup>18</sup>F]fluoro‐<italic>m</italic>‐tyrosine (FMT), which also targets <sc>l</sc>‐amino acid decarboxylase, has potential advantages over FDOPA as a radiotracer because it does not form catechol‐<italic>O</italic>‐methyltransferase (COMT) metabolites. The purpose of the present study was to compare the regional distribution of these radiotracers in the brains of PD patients. Fifteen Parkinson's patients were studied with FMT and FDOPA positron emission tomography (PET) as well as high‐resolution structural magnetic resonance imaging (MRI). MRI's were automatically parcellated into neuroanatomical regions of interest (ROIs) in Freesurfer (<ext-link ext-link-type="uri" xlink:href="http://surfer.nmr.mgh.harvard.edu" xlink:type="simple" xmlns:xlink="http://www.w3.org/1999/xlink">http://surfer.nmr.mgh.harvard.edu</ext-link>); region‐specific uptake rate constants (K<sub>occ</sub>) were generated from coregistered PET using a Patlak graphical approach. The essential findings were as follows: (1) regional K<sub>occ</sub> were highly correlated between the radiotracers and in agreement with a previous FDOPA studies that<abstract abstract-type="main"> <title>ABSTRACT</title> <p>6‐[<sup>18</sup>F]‐Fluoro‐<sc>l</sc>‐dopa (FDOPA) has been widely used as a biomarker for catecholamine synthesis, storage, and metabolism—its intense uptake in the striatum, and fainter uptake in other brain regions, is correlated with the symptoms and pathophysiology of Parkinson's disease (PD). 6‐[<sup>18</sup>F]fluoro‐<italic>m</italic>‐tyrosine (FMT), which also targets <sc>l</sc>‐amino acid decarboxylase, has potential advantages over FDOPA as a radiotracer because it does not form catechol‐<italic>O</italic>‐methyltransferase (COMT) metabolites. The purpose of the present study was to compare the regional distribution of these radiotracers in the brains of PD patients. Fifteen Parkinson's patients were studied with FMT and FDOPA positron emission tomography (PET) as well as high‐resolution structural magnetic resonance imaging (MRI). MRI's were automatically parcellated into neuroanatomical regions of interest (ROIs) in Freesurfer (<ext-link ext-link-type="uri" xlink:href="http://surfer.nmr.mgh.harvard.edu" xlink:type="simple" xmlns:xlink="http://www.w3.org/1999/xlink">http://surfer.nmr.mgh.harvard.edu</ext-link>); region‐specific uptake rate constants (K<sub>occ</sub>) were generated from coregistered PET using a Patlak graphical approach. The essential findings were as follows: (1) regional K<sub>occ</sub> were highly correlated between the radiotracers and in agreement with a previous FDOPA studies that used different ROI selection techniques; (2) FMT K<sub>occ</sub> were higher in extrastriatal regions of relatively large uptake such as amygdala, pallidum, brainstem, hippocampus, entorhinal cortex, and thalamus, whereas cortical K<sub>occ</sub> were similar between radiotracers; (3) while subcortical uptake of both radiotracers was related to disease duration and severity, cortical uptake was not. These results suggest that FMT may have advantages for examining pathologic changes within allocortical loop structures, which may contribute to cognitive and emotional symptoms of PD. <bold>Synapse 68:325–331, 2014</bold>. © 2014 Wiley Periodicals, Inc.</p> </abstract> … (more)
- Is Part Of:
- Synapse. Volume 68:Issue 8(2014:Aug.)
- Journal:
- Synapse
- Issue:
- Volume 68:Issue 8(2014:Aug.)
- Issue Display:
- Volume 68, Issue 8 (2014)
- Year:
- 2014
- Volume:
- 68
- Issue:
- 8
- Issue Sort Value:
- 2014-0068-0008-0000
- Page Start:
- 325
- Page End:
- 331
- Publication Date:
- 2014-04-22
- Subjects:
- Synapses -- Periodicals
612 - Journal URLs:
- http://onlinelibrary.wiley.com/journal/10.1002/(ISSN)1098-2396 ↗
http://onlinelibrary.wiley.com/ ↗ - DOI:
- 10.1002/syn.21745 ↗
- Languages:
- English
- ISSNs:
- 0887-4476
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 8585.880200
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 4249.xml